Pulmonary sarcomatoid carcinoma - The experience of a lung cancer unit
Conclusions: This paper aims to alert for this rare and aggressive tumor, affecting mostly smoking male, which remains poorly explored. The better knowledge of PSC biology and molecular profile is critical for understanding the role of immunotherapy and targeted agents in this difficult to treat disease.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Cunha Machado, D. P., Campainha, S., Conde, S., Sanches, A., Barroso, A. Tags: 11.1 Lung Cancer Source Type: research
More News: Alimta | Biology | Brain | Brain Cancers | Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | CT Scan | Immunotherapy | Lung Cancer | Molecular Biology | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Radiation Therapy | Neoadjuvant Therapy | Neurology | Non-Small Cell Lung Cancer | PET Scan | Radiation Therapy | Respiratory Medicine | Smokers | Study